← Human Trials & Peer-Reviewed Studies
Decorin, a growth hormone-regulated protein in humans.
Plain-language guide to PMID 29138241 (2018): double-blind randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 63 men.
Key Facts
- PMID
- 29138241
- Journal
- European journal of endocrinology
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Bahl N et al. (5 authors)
- DOI
- 10.1530/EJE-17-0844
What This Study Did, in Plain Language
What Was Tested
Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this randomized controlled trial publication.
To determine whether decorin is stimulated by GH and testosterone.
Why It Was Studied
Growth hormone (GH) stimulates connective tissue and muscle growth, an effect that is potentiated by testosterone.
Decorin, a myokine and a connective tissue protein, stimulates connective tissue accretion and muscle hypertrophy.
Who Took Part
The study group was 63 men.
The age groups tagged for this paper are young adults and adults, both men and women.
How the Study Was Run
The design is described as randomized, double-blind and placebo-controlled.
Random assignment meant chance, not the researchers, decided who got Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and who got the comparison, which limits bias.
As a double-blind Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study, the assignments were hidden from both participants and investigators until the end.
The comparison arm used a placebo, so changes seen with Exogenous HGH, sermorelin & older GHRPs (why they're passed over) could be set against what happens without it.
What Was Measured
Growth hormone (GH) stimulates connective tissue and muscle growth, an effect that is potentiated by testosterone.
Whether GH and testosterone regulate decorin in humans is not known.
PubMed files the paper under topics including Androgens, Athletes, Decorin, Human Growth Hormone, Sex Factors and Testosterone.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 63 men.
Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2018 (European journal of endocrinology), a journal based in England.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.